DepoMed (DEPO) files a lawsuit againt Impax Laboratories (IPXL) and Par Pharmaceutical (PRX) for patent infringement covering ANDAs filed by the firms to market generic versions of Gralise. The company fired up a previous lawsuit in March aimed at protecting its exclusivity for the drug.
DepoMed (DEPO) files a lawsuit againt Impax Laboratories (IPXL) and Par Pharmaceutical (PRX) for...
From other sites
at CNBC.com (May 11, 2015)
at CNBC.com (Jan 15, 2015)
at CNBC.com (Mar 13, 2014)
at CNBC.com (Dec 6, 2013)
at CNBC.com (Jun 8, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs